E Abrutyn1, J A Berlin. 1. Medical College of Pennsylvania, Veterans Affairs Medical Center, Section in Infectious Diseases, Philadelphia.
Abstract
OBJECTIVE: --To assess the efficacy of intrathecal therapy with tetanus antibody (antitetanus equine serum or human tetanus immune globulin) in neonatal and adult tetanus using meta-analytical techniques. DATA SOURCES: --Clinical trials identified by searching MEDLINE and by reviewing bibliographies of published articles. STUDY SELECTION: --Studies in English with concurrent controls treated without intrathecal therapy. DATA EXTRACTION: --Data were extracted by one author and verified by the second; conflicts were resolved by discussion. DATA SYNTHESIS: --No major treatment effect was found in neonatal tetanus when all studies were considered. A benefit was suggested for antitetanus equine serum in adult disease, but this finding should be accepted with caution. Subgroup analyses were limited in power. Methodological difficulties in neonatal and adult trials were common and safety has not been established. CONCLUSIONS: --Intrathecal therapy for tetanus with either antitetanus equine serum or human tetanus immune globulin is not of proven benefit and should only be given in the context of well-designed, controlled trials.
OBJECTIVE: --To assess the efficacy of intrathecal therapy with tetanus antibody (antitetanus equine serum or humantetanus immune globulin) in neonatal and adult tetanus using meta-analytical techniques. DATA SOURCES: --Clinical trials identified by searching MEDLINE and by reviewing bibliographies of published articles. STUDY SELECTION: --Studies in English with concurrent controls treated without intrathecal therapy. DATA EXTRACTION: --Data were extracted by one author and verified by the second; conflicts were resolved by discussion. DATA SYNTHESIS: --No major treatment effect was found in neonatal tetanus when all studies were considered. A benefit was suggested for antitetanus equine serum in adult disease, but this finding should be accepted with caution. Subgroup analyses were limited in power. Methodological difficulties in neonatal and adult trials were common and safety has not been established. CONCLUSIONS: --Intrathecal therapy for tetanus with either antitetanus equine serum or humantetanus immune globulin is not of proven benefit and should only be given in the context of well-designed, controlled trials.
Authors: J J Farrar; L M Yen; T Cook; N Fairweather; N Binh; J Parry; C M Parry Journal: J Neurol Neurosurg Psychiatry Date: 2000-09 Impact factor: 10.154
Authors: Huynh Thi Loan; Lam Minh Yen; Evelyne Kestelyn; Nguyen Van Hao; Nguyen Thi Hoang Mai; Duong Bich Thuy; Ha Thi Hai Duong; Nguyen Thi Phuong Dung; Nguyen Hoan Phu; Pham Thi Lieu; Tran Tan Thanh; Ronald Geskus; H Rogier van Doorn; Le Van Tan; Duncan Wyncoll; Nicholas P J Day; Tran Tinh Hien; Guy E Thwaites; Nguyen Van Vinh Chau; C Louise Thwaites Journal: Am J Trop Med Hyg Date: 2018-06-14 Impact factor: 2.345
Authors: Huỳnh Thị Loan; Lam Minh Yen; Evelyne Kestelyn; Nguyen Van Hao; Tran Tan Thanh; Nguyen Thi Phuong Dung; Hugo C Turner; Ronald B Geskus; Marcel Wolbers; Le Van Tan; H Rogier Van Doorn; Nicholas P Day; Duncan Wyncoll; Tran Tinh Hien; Guy E Thwaites; Nguyen Van Vinh Chau; C Louise Thwaites Journal: Wellcome Open Res Date: 2018-11-05